Department of Science and Technology
The Indian government set the country’s research community aflutter when it announced the launch of a long-awaited plan to improve research access without announcing many of its salient details as well. On November 25, the Ministry of Education published a press release saying the Union Cabinet had approved the
Biocon
Apparently (and surprisingly) The Telegraph didn’t allow Dinesh Thakur to respond to an article by Biocon employee Sundar Ramanan, in which Ramanan deems Thakur’s article about the claims to efficacy of the Biocon drug Itolizumab not being backed by enough data to have received the DCGI’s approval
for-profit publishing
Is it just me or does everyone see a self-fulfilling prophecy here? These News & Views articles assess the importance and lasting impact of 10 key papers from our archive, from the finding of the first exoplanet to the discovery of the Antarctic ozone hole. #Nature150 https://t.co/d4Cq26wJXE
